Novartis AG Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (55)

Latest Posts

About This Stock More About This Stock
4 Biotech Stocks To Watch In The New Year
Article By: Zacks Investment Research
Sunday, January 7, 2018 5:23 PM EST
Biotech companies are continuously working on bringing innovative new treatments to market, and there could be significant catalysts in the coming quarters in the form of important product approvals as well as major data read-outs.
In this article: EBS, GSK, MDCO, XOMA, EXEL, NVS, MLNT
Read
Pharma Stock Roundup: Roche, MNK Announce Acquisition Agreements, Regulatory Updates From Novartis
Article By: Arpita Dutt
Saturday, December 30, 2017 7:49 PM EST
Key announcements in the pharma space this week include a couple of acquisition announcements and regulatory updates from Novartis.
In this article: AGN, AZN, BMY, GSK, NVS, RHHBY, MNK
Read
3 Heart Disease Focused Stocks To Buy Ahead Of World Heart Day
Article By: Arpita Dutt
Tuesday, September 26, 2017 1:06 PM EST
With World Heart Day coming up, let’s take a look at some well-positioned stocks in this segment of the market.
In this article: BEAT, EW, NVS Also: MRK, NVO, LLY
Read
Finally… A Cure For Cancer?
Article By: Marc Lichtenfeld
Monday, September 4, 2017 5:31 PM EST
Novartis’ CAR-T therapy Kymriah got the green light from U.S. regulators to treat children and young adults with B-cell acute lymphoblastic leukemia who aren’t responding to other more conventional treatments.
In this article: NVS Also: GILD, KITE, AMGN, CELG
Read
HH Biotech Bonanza: The Next Leg Up For Biotech Stocks
Article By: Tarun Chandra, CFA
Friday, September 1, 2017 8:05 PM EST
The Biotechnology sector remains one of the top performing sectors this year with the benchmark Nasdaq Biotechnology Index of biotech stocks, as represented by the biotech ETF (IBB​), gaining 17% in the first half.
In this article: NVS, PFE, IBB, GILD, VRTX, XBI, XLV, ONCE, LABU
Read

PARTNER HEADLINES

Latest Tweets for $NVS

No tweets yet!

$NVS

OncoSec Raising Its Profile In Fight Against Cancer
BreakingBad News 9/6/2017 3:48:05 PM

More good news on the war against #Cancer, thanks. #Novartis also has made great progress against B-cell acute lymphoblastic leukemia: www.talkmarkets.com/.../finally-a-cure-for-cancer $ONCS $NVS

Finally… A Cure for Cancer?
BreakingBad News 9/6/2017 3:30:54 PM

Lot of good news against the war on #Cancer. Also just read this about #OncoSec: www.talkmarkets.com/.../oncosec-raising-its-profile-in-fight-against-cancer $ONCS $NVS

Novartis Receives FDA Approval For An Acute Myeloid Leukemia Drug
Terry Chrisomalis 5/1/2017 12:22:24 AM

Yes it does indeed. #Novartis has been doing very well lately. $NVS

Novartis Receives FDA Approval For An Acute Myeloid Leukemia Drug
Danielle Rogers 4/30/2017 5:29:49 PM

Triple the effectiveness over a placebo looks very promising! $NVS

1 to 5 of 5 comments